title: Tissue Engineering of Ureteral Grafts: Preparation of Biocompatible Crosslinked Ureteral Scaffolds of Porcine Origin.
abstract: The surgical reconstruction of ureteric defects is often associated with post-operative complications and requires additional medical care. Decellularized ureters originating from porcine donors could represent an alternative therapy. Our aim was to investigate the possibility of manufacturing decellularized ureters, the characteristics of the extracellular matrix (ECM) and the biocompatibility of these grafts in vitro/in vivo after treatment with different crosslinking agents. To achieve these goals, native ureters were obtained from pigs and were decellularized. The success of decellularization and the ECM composition were characterized by (immuno)histological staining methods and a DNA-assay. In vitro: scaffolds were crosslinked either with carbodiimide (CDI), genipin (GP), glutaraldehyde, left chemically untreated or were lyophilized. Scaffolds in each group were reseeded with Caco2, LS48, 3T3 cells, or native rat smooth muscle cells (SMC). After 2 weeks, the number of ingrown cells was quantified. In vivo: crosslinked scaffolds were implanted subcutaneously into rats and the type of infiltrating cells were determined after 1, 9, and 30 days. After decellularization, scaffold morphology and composition of ECM were maintained, all cellular components were removed, DNA destroyed and strongly reduced. In vitro: GP and CDI scaffolds revealed a higher number of ingrown 3T3 and SMC cells as compared to untreated scaffolds. In vivo: at day 30, implants were predominantly infiltrated by fibroblasts and M2 anti-inflammatory macrophages. A maximum of MMP3 was observed in the CDI group at day 30. TIMP1 was below the detection limit. In this study, we demonstrated the potential of decellularization to create biocompatible porcine ureteric grafts, whereas a CDI-crosslink may facilitate the remodeling process. The use of decellularized ureteric grafts may represent a novel therapeutic method in reconstruction of ureteric defects.
authors.affiliation: Translational Centre for Regenerative Medicine (TRM), University of Leipzig , Leipzig , Germany.
authors.forename: Holger
authors.initials: H
authors.lastname: Koch
authors.affiliation: Institute of Anatomy, Faculty of Medicine, University of Leipzig , Leipzig , Germany.
authors.forename: Niels
authors.initials: N
authors.lastname: Hammer
authors.affiliation: Heart Center, Clinic for Cardiac Surgery, University of Leipzig , Leipzig , Germany.
authors.forename: Susann
authors.initials: S
authors.lastname: Ossmann
authors.affiliation: Institute of Pathology, University of Leipzig , Leipzig , Germany.
authors.forename: Katrin
authors.initials: K
authors.lastname: Schierle
authors.affiliation: Translational Centre for Regenerative Medicine (TRM), University of Leipzig , Leipzig , Germany ; Institute for Clinical Immunology, Faculty of Medicine, University of Leipzig , Leipzig , Germany.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Sack
authors.affiliation: Institut für Nichtklassische Chemie e. V. , Leipzig , Germany.
authors.forename: Jörg
authors.initials: J
authors.lastname: Hofmann
authors.affiliation: Institut für Nichtklassische Chemie e. V. , Leipzig , Germany.
authors.forename: Mike
authors.initials: M
authors.lastname: Wecks
authors.affiliation: Translational Centre for Regenerative Medicine (TRM), University of Leipzig , Leipzig , Germany ; Institute for Clinical Immunology, Faculty of Medicine, University of Leipzig , Leipzig , Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Boldt
keywords: crosslinking; decellualrization; scaffold; tissue engineering; ureter